Eva Cavallin-Ståhl
1 – 10 of 87
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Androgen receptor gene CAG and GGN repeat lengths as predictors of recovery of spermatogenesis following testicular germ cell cancer treatment
(
- Contribution to journal › Article
- 2016
-
Mark
The SWENOTECA group: A good example of continuous binational and multidisciplinary collaboration for patients with testicular cancer in Sweden and Norway
(
- Contribution to journal › Article
-
Mark
Treatment of stage I seminoma, with one course of adjuvant carboplatin or surveillance, risk-adapted recommendations implementing patient autonomy : A report from the Swedish and Norwegian Testicular Cancer Group (SWENOTECA)
(
- Contribution to journal › Article
- 2015
-
Mark
Sick leave and disability pension among Swedish testicular cancer survivors according to clinical stage and treatment
(
- Contribution to journal › Article
- 2014
-
Mark
Treatment of oral mucositis pain following radiation therapy for head-and-neck cancer using a bioadhesive barrier-forming lipid solution
(
- Contribution to journal › Article
-
Mark
Inhibin B concentration is predictive for long-term azoospermia in men treated for testicular cancer.
(
- Contribution to journal › Article
-
Mark
One Course of Adjuvant BEP in Clinical Stage I Nonseminoma Mature and Expanded Results from the SWENOTECA group.
(
- Contribution to journal › Article
- 2013
-
Mark
Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer
(
- Contribution to journal › Scientific review
- 2012
-
Mark
High-dose chemotherapy with autologous stem cell support in patients with metastatic non-seminomatous testicular cancer - a report from the Swedish Norwegian Testicular Cancer Group (SWENOTECA)
(
- Contribution to journal › Article
-
Mark
Testicular-cancer survivors experience compromised language following chemotherapy: Findings in a Swedish population-based study 3-26 years after treatment
(
- Contribution to journal › Article